Pediatric Acne Update
Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children’s Hospital-San Diego and Professor of Dermatology and Pediatrics and Vice-chair of the Department of Dermatology at UC San Diego School of Medicine, discusses recent advances in treating pediatric acne including the use of Cabtreo (clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide, Ortho Dermatologics) and spironolactone […]
A Sneak Peek in the Toxin Pipeline
Novel neuromodulator products including ready-to-go liquid formulations and new indications for existing toxins promise to further invigorate the aesthetic landscape in 2024 and beyond. Joel L. Cohen, MD, Director of About Skin Dermatology and DermSurgery in Greenwood Village and Lone Tree, CO, updates viewers on what may be coming down the pike.
Heart of the Matter: Understanding CV Risk in Psoriasis
Joel M Gelfand, MD, MSCE, the James J. Leyden Professor of Dermatology & Epidemiology, Director of the Center for Clinical Sciences in Dermatology, Director Psoriasis & Phototherapy Treatment Center at the University of Pennsylvania Perelman School of Medicine in Philadelphia, highlights recent research on cardiovascular risk in psoriasis and stresses the importance of multidisciplinary care […]
Managing Patient Expectations in Vitiligo
Treating vitiligo is a marathon, not a sprint, and it’s important that patients understand this when starting therapy, explains John E. Harris, MD, PhD, the founding Director of the Vitiligo Clinic and Research Center, founding director of the Autoimmune Therapeutics Institute and Professor and Chair in the Department of Dermatology at UMass Chan Medical School in […]
Deucravacitinib Shows Efficacy Signal in Cutaneous Lupus Erythematosus
Deucravacitinib (Sotyktu, Bristol-Myers Squibb) may help improve cutaneous manifestations in patients with systemic lupus erythematosus, according to a late-breaking study presented at MauiDerm 2024. Deucravacitinib is a first-in-class, oral, selective, allosteric tyrosine kinase 2 inhibitor approved in multiple countries for the treatment of adults with moderate to severe plaque psoriasis. In the 48-week, double-blind, phase […]
Harnessing Skin Cancer Genes to Heal Hearts
BRAF mutations in skin cancers may help repair cardiac muscle after a heart attack, according to a study in Science Advances. BRAF is a part of the MAPK signaling pathway that can promote cell division, In a new study, researchers show that introducing this mutation to rat heart tissue grown in a laboratory can induce growth. “Mature […]